Last reviewed · How we verify
Propofol 1 % Injectable Suspension
At a glance
| Generic name | Propofol 1 % Injectable Suspension |
|---|---|
| Also known as | Propofol, Diprivan, propofol |
| Sponsor | Sindh Institute of Urology and Transplantation |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Comparison Between Sevoflurane and Propofol for Maintenance of Sedation During ERCP (PHASE4)
- TIVA vs TXA in Sinus Surgery to Evaluate Operative Blood Loss and Surgical Field Quality (NA)
- Monitored Anesthesia Care Versus Intubated General Anesthesia for Open Heart Surgery Under Cardiopulmonary Bypass (NA)
- Quantitative Electroencephalogram and Bispectral Index Brain Mapping During Propofol vs Sevoflurane General Anesthesia
- Autologous Peripheral Blood Mononuclear Cells in Diabetic Foot Patients With No-option Critical Limb Ischemia (NA)
- Lavender Oil on Preoperative Anxiety and Sedation Requirement in General Anaesthesia (NA)
- Laparoscopic Cholecystectomy: General Anesthesia With Opioid Versus General Opioid Free Anesthesia (PHASE4)
- Bone Marrow as an Alternative Site for Islet Transplantation (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: